For instance, methods such as mAb to inhibit highly expressed IL-27 in CD14+ monocytes in patients with RA may reverse severe RA disease and suppress highly expressed pro-inflammatory components in circulation and local joints. This evidence concerns the gene IL27 and rheumatoid arthritis.